ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1217

The Random Urine Uric Acid to Creatinine Ratio As a Predictor of 24-Hour Urine Uric Acid Excretion in Gout Patients

Sang Tae Choi1, Jung-Soo Song2 and Eun-Hye Park2, 1Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea, 2Chung-Ang University College of Medicine, Seoul, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Gout and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies: Mechanisms of Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Gout is an inflammatory disease resulted from an increased body pool of uric acid. The measurement of 24-hour uric acid excretion is important to evaluate the disease status as well as to select the kind of uric acid lowering agents. However, 24-hour urine collection is inconvenient, and frequently unreliable due to errors in collection. The average person excretes approximately 1 g/day creatinine, and thus a lot of studies showed that the random urine protein to creatinine ratio was well correlated with 24-hour urine protein excretion rate. In this study, we investigated the utility of the random urine uric acid to creatinine ratio for predicting 24-hour urine uric acid excretion in gouty patients.

Methods: The cross-sectional study included 37 gouty patients without any use of uric acid lowering agents. The average age was 47.7 ± 17.7 years old and 34 out of 37 were male patients. 24-hour urine collections of the patients were conducted to the evaluate uric acid excretion and renal function. Random urine uric acid and creatinine specimens were obtained from all participants at the day when 24-hour urine collection was conducted. The creatinine clearance (CCr) was measured from the 24-hour urine collected sample, and chronic kidney disease was defined as the CCr levels below 60 ml/min/1.73m2.

Results: The mean of 24-hour uric acid excretion was 602.4 ± 236.0 mg, and those of serum uric acid levels and CCr values were 7.31 ± 1.31 mg/dl and 100.9 ± 33.2 ml/min/1.73m2, respectively. Random urine uric acid to creatinine ratio was closely correlated with the absolute and log transformed 24-hour urine uric acid excretions (γ = 0.450, p = 0.005;γ = 0.474, p = 0.003, respectively). In the linear regression analysis, the amount of absolute 24-hour urine uric acid excretion was estimated by 0.812 x (random urine uric acid to creatinine ratio) + 290.466 (R2 = 0.450, p = 0.005). The correlation between random urine uric acid to creatinine ratio and 24-hour urine uric acid excretion was also found in the patients with chronic kidney disease (γ = 0.900, p= 0.037). 

Conclusion: Random urine uric acid to creatinine ratio showed positive correlation with the absolute and log transformed 24-hour urine uric acid excretions. The random urine uric acid to creatinine ratio would be a good predictor of 24-hour urine uric acid excretion in gouty patients.


Disclosure:

S. T. Choi,
None;

J. S. Song,
None;

E. H. Park,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-random-urine-uric-acid-to-creatinine-ratio-as-a-predictor-of-24-hour-urine-uric-acid-excretion-in-gout-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology